Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

With Its Second Deal in Two Weeks, This Tiny Biotech Is Revving Up for a Run

Two weeks.

Two big deals.

Two big trading days for a promising biotech.

Shares of our "Liquid Biopsy" play TrovaGene Inc. (Nasdaq: TROV) rocketed as much as 23% today after the tiny biotech announced its second major deal in the last two weeks.

Another deal - announced back on Jan. 21 - ignited a single-day gain of 70%.

Leave a Reply

Your email address will not be published. Required fields are marked *

Some HTML is OK